Relisys Medical Devices

What Relisys Medical Devices does

Relisys Medical Devices Limited is a Hyderabad-based, privately held manufacturer of cardiovascular medical devices founded in 2003, operating from an integrated facility in Ibrahimpatnam, Ranga Reddy, Telangana. The company develops and produces bare-metal and drug-eluting coronary stent systems built on cobalt-chromium (L-605) platforms with strut thicknesses as low as 59µm, biodegradable PLLA/PLGA polymer coatings, and Sirolimus or Everolimus drug-eluting chemistries. Its portfolio extends to PTCA balloon catheters (pre- and post-dilatation), guide and diagnostic catheters, microcatheters, embolectomy and sizing catheters, transcatheter heart valves (TricValve and Vienna Valve via a P+F joint venture), and a recently expanded peripheral and endovascular line covering drug-coated balloons, peripheral stents, and aortic stent grafts. Newer categories include drug-coated coronary balloons (Pearl DCB), cutting balloons (Pearl CB), and a coronary intravascular lithotripsy system (Matrix IVL).

Relisys serves hospitals, cardiac care centers, and interventional cardiologists performing percutaneous coronary interventions, structural heart procedures, and peripheral vascular interventions. The company monetizes through direct sales of branded devices, OEM and contract manufacturing services leveraging its integrated development and sterilization capabilities, and international distribution of CE marked products acquired through its 2023 acquisition of Multimedics. It holds ISO 13485:2016 certification covering the full device lifecycle. Go-to-market is enterprise field sales targeting hospital procurement and cath lab physicians, supported by physician testimonial content, medical conference presence, and a multi-channel digital footprint.

The company claims to have developed India's first indigenous coronary stent system and is positioned as an affordable alternative to imported international brands while maintaining ISO 13485 quality standards. Operational scale is anchored by a self-reported milestone of more than one million stents deployed cumulatively, and product breadth now spans the full interventional cardiology and peripheral vascular continuum. Ownership is private and bootstrapped, with no institutional venture or private equity investment disclosed in the available data.

Name

Relisys Medical Devices

Legal name

Relisys Medical Devices Limited

Website

https://relisysmedicaldevices.org

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

251–500 employees

Short description

Relisys Medical Devices is a Hyderabad-based manufacturer of cardiovascular devices including coronary stents, balloon catheters, and transcatheter heart valves, serving hospitals and interventional cardiologists in India and international markets via direct sales, OEM services, and CE marked distribution.

Ownership category

akta.pro rank

Product category

Cardiovascular Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Coronary Stents & Drug-Eluting Technologies (HLAHAFAA)

akta.pro secondary industries

Structural Heart Valves (TAVR/SAVR) & Valve Repair (HLAHAFAB), Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK)

Keywords

• Cardiovascular medical devices
• Coronary stent systems
• Drug eluting stents
• PTCA balloon catheters
• Transcatheter heart valves

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of cardiovascular medical devices including Coronary Stent Systems, PTCA Balloon Catheters, Catheters, Transcatheter Heart Valves, and accessories. Products sold to hospitals and healthcare providers domestically and internationally.
2. OEM Services: Original Equipment Manufacturing services for other medical device companies, leveraging integrated development and manufacturing capabilities.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Relisys Medical Devices is an integrated developer and manufacturer of cardiovascular medical devices. It produces bare metal and drug eluting coronary stent systems, PTCA balloon catheters, guiding and angiographic diagnostic catheters, and transcatheter heart valves for the treatment of coronary artery disease, tricuspid regurgitation, and peripheral vascular conditions. It also offers contract (OEM) manufacturing services for other medical device companies.

Product overview

Relisys Medical Devices is a manufacturer of cardiovascular medical devices offering a comprehensive portfolio of interventional cardiology and peripheral vascular products. The portfolio includes Bare Metal Stent Systems (Cobal+C, M'Sure-Cr), Drug Eluting Stent Systems with both Sirolimus (M'Sure-S, MyStent-S, Premier+, Release-R, Tapper-S) and Everolimus (ELIMINATOR, Pristine+) coatings, PTCA Balloon Catheters (Pearl, RUBY, VEDA+R series in both NC and SC variants), Catheters (AccessGuide, Amber, Ananth, Embolex, Quartz, Repacath, RELICA, Steerflex), Transcatheter Heart Valves (TRICVALVE, VIENNA VALVE), Coronary Specialty Devices (Pearl CB, Pearl DCB), Intravascular Lithotripsy (Matrix IVL), Coronary Vascular Accessories (Cusp Kit, Gentle, Radiseal, REGAL, Reliport), and Peripheral Vascular Devices (Coral, Avert B, Engross, Engross HP, Peripac S, MetaGraft AAA/TAA). The company operates as an integrated development and manufacturing facility for stents, stent delivery systems, PTCA balloon catheters, guiding catheters, and angiographic diagnostic catheters at its Hyderabad factory.

Differentiator

Problem solved

Functional benefit

Products and services

• Cobal + C (Bare Metal Stent System)

Quantifiable outcome

• Complete endothelialization in 14 days with Cobal+C bare metal stent
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• MultimedicscoreStrategic or Co-development PartnerRelisys acquired Multimedics to expand business portfolio with CE marked Stent Systems and increase global footprints with an entire range of Cardiovascular devices besides Coronary Stents.
• P+F (JV Partner)coreStrategic or Co-development PartnerJoint venture with P+F for manufacturing and distribution of Transcatheter Heart Valves (TricValve and Vienna Valve) for India and parts of Southeast Asia.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Sahajanand Medical Technologies (SMT): India-based manufacturer of drug-eluting coronary stents (Supraflex, Supralimus) — the most direct domestic competitor to Relisys with overlapping DES technology and shared Indian hospital customer base.
• Translumina Therapeutics: Indian manufacturer of cardiovascular devices including DES (Yukon Choice, ProZeta) and related interventional cardiology products, directly competing with Relisys in India and select export markets.
• Meril Life Sciences: Indian medical device company with cardiovascular stent systems (MeRes100), structural heart valves (MyVal), and a broad interventional cardiology portfolio — overlapping with Relisys's DES and TAVR offerings in India and emerging markets.

Broad incumbents

• Abbott Vascular: Global leader in coronary stents (Xience), structural heart, and interventional cardiology — sets the clinical-evidence benchmark that Relisys's DES portfolio must compete against in every market.
• Boston Scientific: Major interventional cardiology incumbent with the Synergy/Promus DES platform and an extensive peripheral vascular portfolio — overlapping across most of Relisys's product categories.
• Medtronic: Global cardiovascular leader across DES (Resolute Onyx), TAVR (Evolut), and peripheral vascular — competes with Relisys at the high end of each category and in OEM/scale benchmarks.
• Merit Medical Systems: Global manufacturer of peripheral intervention, inflation devices, guidewires, and procedural accessories — overlapping with Relisys's catheter, manifold, and access-device portfolio.

Emerging players

• MicroPort Scientific: Chinese-headquartered cardiovascular device manufacturer with DES (Firehawk, Firebird) and structural heart products — comparable as an emerging-market alternative to the Western incumbents.
• Lepu Medical: Chinese interventional cardiology manufacturer with DES platforms (Nano+, Partner) and structural heart devices — competes with Relisys for emerging-market share and as an Asian-origin alternative.

Regional players

• Vascular Concepts: India-headquartered peripheral vascular and endovascular device manufacturer (supra-renal stent grafts, PTA balloons) — directly comparable on the peripheral vascular portion of Relisys's portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@relisysmedicaldevices
• Facebookfacebook.com/relisysmedicaldevices
• LinkedInlinkedin.com/company/relisysmedicaldevices
• Instagraminstagram.com/relisysmedicaldevices
• Xx.com/relisysmedical

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Relisys Medical Devices